These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6249610)

  • 1. Changed Fc and C3 receptor pattern on human EBV-negative lymphoma cells, following in vitro conversion by EB-virus.
    Jønsson VU; Klein G; Christensen BE
    Eur J Cancer (1965); 1980 Apr; 16(4):533-8. PubMed ID: 6249610
    [No Abstract]   [Full Text] [Related]  

  • 2. Fc and C3 receptor patterns on two EBV- negative Burkitt lymphoma lines during acute exposure to EBV (P3HR-1 substrain).
    Jønsson V; Klein G
    Eur J Cancer (1965); 1981 Feb; 17(2):161-5. PubMed ID: 6266834
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
    Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of solid-phase radioimmunoassay specific for human IgG or human C3b to detect Fc gamma or C3b receptors on human lymphoblastoid cell surfaces.
    Frade R; Barel M; Charriaut C
    Methods Enzymol; 1983; 93():155-63. PubMed ID: 6223196
    [No Abstract]   [Full Text] [Related]  

  • 5. Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines.
    Yefenof E; Klein G
    Int J Cancer; 1977 Sep; 20(3):347-52. PubMed ID: 198382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc and C3 receptor expression on human alveolar macrophages in sarcoidosis.
    Rottoli L; Rottoli P; Perari MG
    Sarcoidosis; 1984 Sep; 1(1):55-9. PubMed ID: 6571480
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.
    McConnell I; Klein G; Lint TF; Lachmann PJ
    Eur J Immunol; 1978 Jul; 8(7):453-8. PubMed ID: 211040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
    Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells.
    Theofilopoulos AN; Carson DA; Tavassoli M; Slovin SF; Speers WC; Jensen FB; Vaughan JH
    Arthritis Rheum; 1980 Jan; 23(1):1-9. PubMed ID: 7352929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic markers in the differential diagnosis of non-Hodgkin's lymphomas.
    Stein H; Staudinger M; Tolksdorf G; Lennert K
    J Cancer Res Clin Oncol; 1981; 101(1):29-42. PubMed ID: 7276070
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Immunol; 1988 Jun; 140(11):3867-74. PubMed ID: 2836501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus binding to virus-carrying cell lines is enhanced in the presence of C3 and C3d.
    Wells A; Koide N; Eggertsen G; Lundwall A; Godal T; Steen HB; Klein G
    J Gen Virol; 1984 Mar; 65 ( Pt 3)():507-13. PubMed ID: 6321638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
    Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
    Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein Barr virus (EBV) and complement (C3) interactions with human lymphoid cells.
    Yefenof E
    Haematol Blood Transfus; 1979; 23():237-8. PubMed ID: 232455
    [No Abstract]   [Full Text] [Related]  

  • 15. The Epstein-Barr virus receptor is distinct from the C3 receptor.
    Wells A; Koide N; Stein H; Gerdes J; Klein G
    J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc and C3b receptors on cultured retinoblastoma cells.
    Stein PC; Rand N; Char DH
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):550-3. PubMed ID: 7287344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Fc- and C3-receptors on membranes of blast cells in myeloblastic leukemia and blast crisis of myelocytic leukemia].
    Tishchenko LM; Guseva SA
    Eksp Onkol; 1985; 7(2):51-4. PubMed ID: 3859402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane receptors of human leukaemic myeloid cells: sequential expression of the gamma Fc receptor.
    Burns GF; Cawley JC
    Br J Haematol; 1979 Aug; 42(4):499-505. PubMed ID: 289408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
    Yamamoto N; Mitsuma T; Vogt A
    J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in EBV receptor concentration between in vitro EBV-converted lymphoma sublines reflect biological differences between the converting viral substrains.
    Klein G; Manneborg A; Steinitz M
    Int J Cancer; 1979 Feb; 23(2):197-200. PubMed ID: 216641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.